This report offers companies, investors, policymakers, and stakeholders crucial insight into the rich ecosystem of pharmaceuticals, biotech, and healthcare companies in Indonesia, based on in-depth interviews conducted with leaders and pioneers across the value chain, from the Ministries of Health and Industry, the leaders of the Indonesian public procurement and social security institutes, country managers of the world’s leading biopharmaceutical companies, and representatives from local SMEs and service providers.
In Profile / Moderna Maintains it mRNA Wager
Having been quietly working away on its mRNA platform for years, Moderna stepped into the limelight during the COVID-19 pandemic and became a commercial-stage outfit almost overnight with its vaccine.…
